Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

A spirulina-enhanced diet provides neuroprotection in an α-synuclein model of Parkinson's disease.

Pabon MM, Jernberg JN, Morganti J, Contreras J, Hudson CE, Klein RL, Bickford PC.

PLoS One. 2012;7(9):e45256. doi: 10.1371/journal.pone.0045256. Epub 2012 Sep 18.

PMID:
23028885
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.

Marinova-Mutafchieva L, Sadeghian M, Broom L, Davis JB, Medhurst AD, Dexter DT.

J Neurochem. 2009 Aug;110(3):966-75. doi: 10.1111/j.1471-4159.2009.06189.x. Epub 2009 Jun 22.

PMID:
19549006
[PubMed - indexed for MEDLINE]
3.

Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.

Hayashita-Kinoh H, Yamada M, Yokota T, Mizuno Y, Mochizuki H.

Biochem Biophys Res Commun. 2006 Mar 24;341(4):1088-95. Epub 2006 Jan 25.

PMID:
16460685
[PubMed - indexed for MEDLINE]
4.

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.

Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J.

FASEB J. 2005 Apr;19(6):533-42.

PMID:
15791003
[PubMed - indexed for MEDLINE]
Free Article
5.

Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.

Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, Kim S, Lee D, Chung H, Oh MS, Lee KT, Park S.

Neurotox Res. 2009 May;15(4):332-47. doi: 10.1007/s12640-009-9037-x. Epub 2009 Mar 17.

PMID:
19384567
[PubMed - indexed for MEDLINE]
6.

Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.

Sanchez-Guajardo V, Febbraro F, Kirik D, Romero-Ramos M.

PLoS One. 2010 Jan 20;5(1):e8784. doi: 10.1371/journal.pone.0008784.

PMID:
20098715
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease.

Shan S, Hong-Min T, Yi F, Jun-Peng G, Yue F, Yan-Hong T, Yun-Ke Y, Wen-Wei L, Xiang-Yu W, Jun M, Guo-Hua W, Ya-Ling H, Hua-Wei L, Ding-Fang C.

Neurobiol Aging. 2011 Mar;32(3):443-58. doi: 10.1016/j.neurobiolaging.2009.03.004. Epub 2009 Apr 14.

PMID:
19368990
[PubMed - indexed for MEDLINE]
8.

Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats.

Salama M, Helmy B, El-Gamal M, Reda A, Ellaithy A, Tantawy D, Mohamed M, El-Gamal A, Sheashaa H, Sobh M.

Environ Toxicol Pharmacol. 2013 Mar;35(2):270-7. doi: 10.1016/j.etap.2012.12.008. Epub 2013 Jan 7.

PMID:
23357603
[PubMed - indexed for MEDLINE]
9.

Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.

Wilms H, Zecca L, Rosenstiel P, Sievers J, Deuschl G, Lucius R.

Curr Pharm Des. 2007;13(18):1925-8. Review.

PMID:
17584117
[PubMed - indexed for MEDLINE]
10.

Blueberry- and spirulina-enriched diets enhance striatal dopamine recovery and induce a rapid, transient microglia activation after injury of the rat nigrostriatal dopamine system.

Strömberg I, Gemma C, Vila J, Bickford PC.

Exp Neurol. 2005 Dec;196(2):298-307. Epub 2005 Sep 19.

PMID:
16176814
[PubMed - indexed for MEDLINE]
11.

CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease.

Pabon MM, Bachstetter AD, Hudson CE, Gemma C, Bickford PC.

J Neuroinflammation. 2011 Jan 25;8:9. doi: 10.1186/1742-2094-8-9.

PMID:
21266082
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease.

Gonzalo-Gobernado R, Calatrava-Ferreras L, Reimers D, Herranz AS, Rodríguez-Serrano M, Miranda C, Jiménez-Escrig A, Díaz-Gil JJ, Bazán E.

PLoS One. 2013 Jul 4;8(7):e67771. doi: 10.1371/journal.pone.0067771. Print 2013.

PMID:
23861803
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein.

Monti B, Gatta V, Piretti F, Raffaelli SS, Virgili M, Contestabile A.

Neurotox Res. 2010 Feb;17(2):130-41. doi: 10.1007/s12640-009-9090-5. Epub 2009 Jul 21.

PMID:
19626387
[PubMed - indexed for MEDLINE]
14.

Mutant alpha-synuclein overexpression mediates early proinflammatory activity.

Su X, Federoff HJ, Maguire-Zeiss KA.

Neurotox Res. 2009 Oct;16(3):238-54. doi: 10.1007/s12640-009-9053-x. Epub 2009 Apr 28.

PMID:
19526281
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

L'Episcopo F, Tirolo C, Caniglia S, Testa N, Serra PA, Impagnatiello F, Morale MC, Marchetti B.

J Neuroinflammation. 2010 Nov 23;7:83. doi: 10.1186/1742-2094-7-83.

PMID:
21092260
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.

Febbraro F, Andersen KJ, Sanchez-Guajardo V, Tentillier N, Romero-Ramos M.

Exp Neurol. 2013 Sep;247:45-58. doi: 10.1016/j.expneurol.2013.03.017. Epub 2013 Mar 24.

PMID:
23531432
[PubMed - indexed for MEDLINE]
17.

Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.

Reynolds AD, Banerjee R, Liu J, Gendelman HE, Mosley RL.

J Leukoc Biol. 2007 Nov;82(5):1083-94. Epub 2007 Aug 3.

PMID:
17675560
[PubMed - indexed for MEDLINE]
Free Article
18.
19.

Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.

Zecca L, Wilms H, Geick S, Claasen JH, Brandenburg LO, Holzknecht C, Panizza ML, Zucca FA, Deuschl G, Sievers J, Lucius R.

Acta Neuropathol. 2008 Jul;116(1):47-55. doi: 10.1007/s00401-008-0361-7. Epub 2008 Mar 15.

PMID:
18343932
[PubMed - indexed for MEDLINE]
20.

Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.

Carta AR, Frau L, Pisanu A, Wardas J, Spiga S, Carboni E.

Neuroscience. 2011 Oct 27;194:250-61. doi: 10.1016/j.neuroscience.2011.07.046. Epub 2011 Jul 27.

PMID:
21839812
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk